Additional Information

Description

Medroxyprogesterone 150 mg/mL single-dose vial is a progestin used for contraception and hormone-related conditions. It is administered as an intramuscular injection and provides long-acting contraceptive effects by inhibiting ovulation and altering cervical mucus. It is indicated for women seeking a reliable, long-term contraceptive option and for specific hormone-related disorders requiring progestin therapy.

The mechanism of action involves suppression of gonadotropin secretion, preventing follicular maturation and ovulation. It induces endometrial atrophy, reducing the likelihood of implantation. The alteration of cervical mucus creates a barrier to sperm penetration, further enhancing contraceptive effectiveness.

Common side effects include menstrual irregularities, weight changes, headache, dizziness, and breast tenderness. Long-term use may be associated with decreased bone mineral density, necessitating periodic evaluation, especially in adolescent and premenopausal women.